Zi-Jun Wang1, Jennifer A Martin1, Lauren E Mueller1, Aaron Caccamise1, Craig T Werner1, Rachael L Neve2, Amy M Gancarz1, Jun-Xu Li3, David M Dietz4. 1. Department of Pharmacology and Toxicology, State University of New York at Buffalo, Buffalo, New York; Research Institute on Addictions, Program in Neuroscience, Department of Psychology, State University of New York at Buffalo, Buffalo, New York. 2. Department of Brain and Cognitive Sciences, Massachusetts Institute of Technology, Cambridge, Massachusetts. 3. Department of Pharmacology and Toxicology, State University of New York at Buffalo, Buffalo, New York. 4. Department of Pharmacology and Toxicology, State University of New York at Buffalo, Buffalo, New York; Research Institute on Addictions, Program in Neuroscience, Department of Psychology, State University of New York at Buffalo, Buffalo, New York; Department of Psychology, California State University Bakersfield, Bakersfield, California. Electronic address: ddietz@buffalo.edu.
Abstract
BACKGROUND: Drug addiction is defined as a chronic disease characterized by compulsive drug seeking and episodes of relapse despite prolonged periods of drug abstinence. Neurobiological adaptations, including transcriptional and epigenetic alterations in the nucleus accumbens, are thought to contribute to this life-long disease state. We previously demonstrated that the transcription factor SMAD3 is increased after 7 days of withdrawal from cocaine self-administration. However, it is still unknown which additional factors participate in the process of chromatin remodeling and facilitate the binding of SMAD3 to promoter regions of target genes. Here, we examined the possible interaction of BRG1-also known as SMARCA4, an adenosine triphosphatase-containing chromatin remodeler-and SMAD3 in response to cocaine exposure. METHODS: The expression of BRG1, as well as its binding to SMAD3 and target gene promoter regions, was evaluated in the nucleus accumbens and dorsal striatum of rats using western blotting, co-immunoprecipitation, and chromatin immunoprecipitation following abstinence from cocaine self-administration. Rats were assessed for cocaine-seeking behaviors after either intra-accumbal injections of the BRG1 inhibitor PFI3 or viral-mediated overexpression of BRG1. RESULTS: After withdrawal from cocaine self-administration, BRG1 expression and complex formation with SMAD3 are increased in the nucleus accumbens, resulting in increased binding of BRG1 to the promoter regions of Ctnnb1, Mef2d, and Dbn1. Intra-accumbal infusion of PFI3 attenuated, whereas viral overexpression of Brg1 enhanced, cocaine-reinstatement behavior. CONCLUSIONS: BRG1 is a key mediator of the SMAD3-dependent regulation of cellular and behavioral plasticity that mediates cocaine seeking after a period of withdrawal.
BACKGROUND:Drug addiction is defined as a chronic disease characterized by compulsive drug seeking and episodes of relapse despite prolonged periods of drug abstinence. Neurobiological adaptations, including transcriptional and epigenetic alterations in the nucleus accumbens, are thought to contribute to this life-long disease state. We previously demonstrated that the transcription factor SMAD3 is increased after 7 days of withdrawal from cocaine self-administration. However, it is still unknown which additional factors participate in the process of chromatin remodeling and facilitate the binding of SMAD3 to promoter regions of target genes. Here, we examined the possible interaction of BRG1-also known as SMARCA4, an adenosine triphosphatase-containing chromatin remodeler-and SMAD3 in response to cocaine exposure. METHODS: The expression of BRG1, as well as its binding to SMAD3 and target gene promoter regions, was evaluated in the nucleus accumbens and dorsal striatum of rats using western blotting, co-immunoprecipitation, and chromatin immunoprecipitation following abstinence from cocaine self-administration. Rats were assessed for cocaine-seeking behaviors after either intra-accumbal injections of the BRG1 inhibitor PFI3 or viral-mediated overexpression of BRG1. RESULTS: After withdrawal from cocaine self-administration, BRG1 expression and complex formation with SMAD3 are increased in the nucleus accumbens, resulting in increased binding of BRG1 to the promoter regions of Ctnnb1, Mef2d, and Dbn1. Intra-accumbal infusion of PFI3 attenuated, whereas viral overexpression of Brg1 enhanced, cocaine-reinstatement behavior. CONCLUSIONS:BRG1 is a key mediator of the SMAD3-dependent regulation of cellular and behavioral plasticity that mediates cocaine seeking after a period of withdrawal.
Authors: W A Carlezon; J Thome; V G Olson; S B Lane-Ladd; E S Brodkin; N Hiroi; R S Duman; R L Neve; E J Nestler Journal: Science Date: 1998-12-18 Impact factor: 47.728
Authors: Jerry E Chipuk; Susan C Cornelius; Nicole J Pultz; Joan S Jorgensen; Michael J Bonham; Seong-Jin Kim; David Danielpour Journal: J Biol Chem Date: 2001-11-13 Impact factor: 5.157
Authors: Yang Yu; Ying Chen; Bongwoo Kim; Haibo Wang; Chuntao Zhao; Xuelian He; Lei Liu; Wei Liu; Lai Man N Wu; Meng Mao; Jonah R Chan; Jiang Wu; Q Richard Lu Journal: Cell Date: 2013-01-17 Impact factor: 41.582
Authors: HaoSheng Sun; Jennifer A Martin; Craig T Werner; Zi-Jun Wang; Diane M Damez-Werno; Kimberly N Scobie; Ning-Yi Shao; Caroline Dias; Jacqui Rabkin; Ja Wook Koo; Amy M Gancarz; Ezekiell A Mouzon; Rachael L Neve; Li Shen; David M Dietz; Eric J Nestler Journal: J Neurosci Date: 2016-04-06 Impact factor: 6.167
Authors: Craig T Werner; Rathipriya Viswanathan; Jennifer A Martin; Pedro H Gobira; Swarup Mitra; Shruthi A Thomas; Zi-Jun Wang; Jian-Feng Liu; Andrew F Stewart; Rachael L Neve; Jun-Xu Li; Amy M Gancarz; David M Dietz Journal: Biol Psychiatry Date: 2018-07-21 Impact factor: 13.382
Authors: Craig T Werner; Swarup Mitra; Benjamin D Auerbach; Zi-Jun Wang; Jennifer A Martin; Andrew F Stewart; Pedro H Gobira; Madoka Iida; Chunna An; Moriah M Cobb; Aaron Caccamise; Richard J Salvi; Rachael L Neve; Amy M Gancarz; David M Dietz Journal: Proc Natl Acad Sci U S A Date: 2020-10-05 Impact factor: 11.205
Authors: Jennifer A Martin; Aaron Caccamise; Craig T Werner; Rathipriya Viswanathan; Jessie J Polanco; Andrew F Stewart; Shruthi A Thomas; Fraser J Sim; David M Dietz Journal: Neuropsychopharmacology Date: 2017-12-20 Impact factor: 7.853
Authors: Xuan Li; Maria B Carreria; Kailyn R Witonsky; Tamara Zeric; Olivia M Lofaro; Jennifer M Bossert; Jianjun Zhang; Felicia Surjono; Christopher T Richie; Brandon K Harvey; Hyeon Son; Christopher W Cowan; Eric J Nestler; Yavin Shaham Journal: Biol Psychiatry Date: 2017-12-29 Impact factor: 13.382
Authors: Jian-Feng Liu; Robert Seaman; Justin N Siemian; Rohan Bhimani; Bernard Johnson; Yanan Zhang; Qing Zhu; Marius C Hoener; Jinwoo Park; David M Dietz; Jun-Xu Li Journal: Neuropsychopharmacology Date: 2018-02-05 Impact factor: 7.853